See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
US Elections
Social Media
Senate
Basketball
Donald Trump
Artificial Intelligence
Recession
Education
Innovation
Golf
Baseball
Published • loading... • Updated

Pfizer Considers Relocating Overseas Manufacturing to US Facilities

Summary
CEO Albert Bourla outlines contingency plans as Trump administration threatens 25% tariffs on imported pharmaceuticals.

15 Articles

All
Left
2
Center
5
Right
2
Business InsiderBusiness Insider

Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US

"I was expecting him probably to win," Pfizer's CEO Albert Bourla said of President Donald Trump's election victory.Leigh Vogel via Getty Images; Carl Court via Getty ImagesPfizer's CEO said he may move manufacturing back to the US in response to Donald Trump's tariffs.Albert Bourla said he was not surprised by Trump's victory in November.Trump has threatened to impose tariffs on Mexico, Canada, and China.Albert Bourla, Pfizer's CEO, said on Mon…

·United States
Read Full Article
fiercepharma.comfiercepharma.com

Pfizer could shift overseas production to US if Trump's pharma tariffs take hold, CEO says

Pfizer's CEO said the company could shift some overseas drug production to the U.S. if import tariffs floated by President Donald Trump take effect.

Read Full Article
Irish IndependentIrish Independent

Pfizer says more drugs can be made in its US plants for domestic market, if needed

Pfizer CEO Albert Bourla said on Monday that the drugmaker can shift manufacturing for the US market to its existing plants in the US, as the threat of tariffs puts a question mark over global supply chains.

·Ireland
Read Full Article
Irish ExaminerIrish Examiner

Pfizer may bring some overseas manufacturing to US if required, says chief exec

'If something happens, we will try to mitigate by transferring from manufacturing sites outside to manufacturing sites here'

·Ireland
Read Full Article
Business StandardBusiness Standard

Pfizer may move outside manufacturing plants to US: CEO amid tariff threats

The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on most goods from Mexico and Canada

·India
Read Full Article
Investing.comInvesting.com

Pfizer considers moving overseas production to U.S. amid tariff threats By Investing.com

Pfizer considers moving overseas production to U.S. amid tariff threats

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Reuters broke the news in United Kingdom on Monday, March 3, 2025.
Sources are mostly out of (0)

Similar News Topics

Tariffs

Tariffs

Donald Trump

Donald Trump

Business

Business

Pharma

Pharma

Mexico Economy

Mexico Economy

US Immigration

US Immigration

US Economy

US Economy

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal